Safety and toxicity assessment of antisense oligonucleotides in brain-relevant human cellular models
Laura Colar Zanjko, Raúl Andrés-Santamaria, Andrea Balogh, Willeke MC van Roon-Mom, András Dinnyés · 2026
Read Safety and toxicity assessment of antisense oligonucleotides in brain-relevant human cellular models by Laura Colar Zanjko, Raúl Andrés-Santamaria, Andrea Balogh, Willeke MC van Roon-Mom, András Dinnyés (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13560553.txt.
Description
Laura Colar Zanjko and co-authors review safety testing of antisense oligonucleotides in brain-relevant human cell models in a 2026 paper. These short DNA-like drugs can tune gene output and now treat several brain disorders.
Chemical tweaks made the drugs hardier and longer lasting in tissue. The review sorts lab platforms for safety checks: stem-cell neurons, support cells, immune cells, and brain organoids. Each trades speed, maturity, and realism differently. Assays span cell death, calcium signals, and gene and protein profiles. Some sequences predict acute nerve toxicity, which backs systematic screening. As one-patient custom drugs grow, standard safety profiling in human cells becomes vital before dosing.
Catalog record
| CREATOR | Laura Colar Zanjko, Raúl Andrés-Santamaria, Andrea Balogh, Willeke MC van Roon-Mom, András Dinnyés |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 53 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |